{"id":"W2317798338","doi":"10.1136/annrheumdis-2013-eular.1352","title":"FRI0225 Use of abatacept in patients with rheumatoid arthritis from the rhumadata® database: experience as first or second line agent compared with adalimumab and etanercept.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Abatacept; Rheumatoid arthritis; Cohort; Internal medicine; Infliximab; Rheumatology; Biosimilar; Database; Physical therapy; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001636081,0.0002706902,0.0009446172,0.0004927409,0.0001985509,0.001183541,0.0006292241,0.0003425835,0.003304253],"category_scores_gemma":[0.004364543,0.0001594117,0.001047598,0.0009160811,0.0001589831,0.0007360647,0.0003933128,0.0005702844,0.0006997308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000556021,"about_ca_system_score_gemma":0.0006731735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003256691,"about_ca_topic_score_gemma":0.0050994,"domain_scores_codex":[0.998697,0.0004951696,0.0001950753,0.00022446,0.0002726763,0.0001155942],"domain_scores_gemma":[0.9980289,0.000700902,0.0007357062,0.0001481049,0.0001310558,0.0002552165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1342384,0.001577376,0.6478788,0.001809121,0.006110833,0.0006458053,0.0004076084,0.0008028846,0.003114513,0.0003743851,0.02267822,0.180362],"study_design_scores_gemma":[0.0130621,0.008013839,0.945783,0.0004729958,0.005233223,0.002539217,0.0006680473,0.002113268,0.001732275,0.0002720426,0.02001556,0.00009454248],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422279,0.0272193,0.0003443685,0.0008024229,0.0001414424,0.0001378303,0.02364651,0.00006925166,0.005410885],"genre_scores_gemma":[0.9715323,0.004810432,0.0004418165,0.0006000298,0.0001345341,0.00008241622,0.02123552,0.00002297626,0.001139957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003304253,"threshold_uncertainty_score":0.0110538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03975226104480552,"score_gpt":0.2794857182874968,"score_spread":0.2397334572426913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}